Acquisition Rumors Drive Exact Sciences Stock Price Surge, Market Watches Potential Deal Progress

A strategic investor is in advanced negotiations to acquire cancer diagnostics company Exact Sciences (EXAS), a development that propelled its stock price to close nearly 24% higher on Wednesday.